BioNexus Gene Lab (BGLC) Net Equity Issued and Repurchased (2018 - 2019)

BioNexus Gene Lab (BGLC) reported Net Equity Issued and Repurchased of -$69967.0 for Q4 2019, up 83.7% on a YoY basis from -$38088.6 in Q4 2018, and up 83.7% sequentially from -$429130.0 in Q4 2018.

BioNexus Gene Lab (BGLC) Net Equity Issued and Repurchased (2018 - 2019) Analysis & Trends

BioNexus Gene Lab (BGLC) has 2 years of Net Equity Issued and Repurchased data on file, last reported at -$69967.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Linde 237.95 Bn 233.99 Bn 4.26 Bn 3.00 Mn
2 Sherwin Williams 78.17 Bn 77.95 Bn 2.78 Bn -
3 Ecolab 76.02 Bn 75.37 Bn 1.85 Bn -
4 Air Products & Chemicals 66.38 Bn 65.43 Bn 987.40 Mn -
5 Ppg Industries 26.02 Bn 24.40 Bn 1.66 Bn -
6 LyondellBasell Industries 22.51 Bn 19.87 Bn 701.00 Mn -
7 Chemical & Mining Co Of Chile 19.70 Bn 15.83 Bn 778.60 Mn -
8 International Flavors & Fragrances 19.51 Bn 18.95 Bn 1.02 Bn -
9 DuPont de Nemours 18.80 Bn 18.71 Bn 602.00 Mn 84.00 Mn
10 BioNexus Gene Lab 2.82 Mn -1.14 Mn -790.00 -

Historic Data

Download Data
DateValue
Dec 31, 2019 -69,967.00
Dec 31, 2019 -69,967.00
Dec 31, 2018 -429,130.00
Dec 31, 2018 -429,130.00